City of Hallandale Beach Police Officers v. AnaptysBio, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 Case No.: 20-CV-565 TWR (DEB)
IN RE ANAPTYSBIO, INC.
SECURITIES LITIGATION, ORDER GRANTING MOTION TO
DISMISS
14 (ECF No. 49) 15 16 Defendant AnaptysBio has moved to dismiss Plaintiff’s complaint. (“Mot. to Dismiss,” ECF No. 49.) Plaintiff opposes. (“Opp’n,” ECF No. 50.) For the reasons set forth below, the Court GRANTS the motion. BACKGROUND Plaintiffs bring this securities class action against AnaptysBio and several of its current and former senior executives. (Amended Complaint “AC” (ECF No. 45) ¶ 1.) AnaptysBio is a San Diego-based clinical stage biotechnology company that discovers and develops drugs to treat “inflammatory diseases and cancers.” (Id. ¶¶ 2, 25.) The individual Defendants are AnaptysBio’s Chief Executive Officer (“CEO”), Hamza Suria, former Chief Medical Officer, Dr. Marco Londei, and the former Chief Financial Officer, Dominic Piscitelli. …